March 30, 2017
Recommended Topic Related To:

Tobrex

"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.

The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...

A A A

Tobrex




Overdosage
Contraindications

OVERDOSE

Clinically apparent signs and symptoms of an overdose of TOBREX (tobramycin ophthalmic ointment) 0.3% (punctate keratitis, erythema, increased lacrimation, edema and lid itching) may be similar to adverse reaction effects seen in some patients.

CONTRAINDICATIONS

TOBREX (tobramycin ophthalmic ointment) 0.3% is contraindicated in patients with known hypersensitivity to any of its components.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 11/29/2016

Overdosage
Contraindications

Tobrex - User Reviews

Tobrex User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Tobrex sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.